UBS Group AG - IMMIX BIOPHARMA INC ownership

IMMIX BIOPHARMA INC's ticker is and the CUSIP is 45258H106. A total of 8 filers reported holding IMMIX BIOPHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of IMMIX BIOPHARMA INC
ValueSharesWeighting
Q1 2023$4,188
-61.0%
2,301
-50.9%
0.00%
Q4 2022$10,733
-32.9%
4,687
-61.0%
0.00%
Q3 2022$16,000
+45.5%
12,004
+176.8%
0.00%
Q2 2022$11,000
-90.5%
4,337
-86.7%
0.00%
Q4 2021$116,00032,6490.00%
Other shareholders
IMMIX BIOPHARMA INC shareholders Q2 2022
NameSharesValueWeighting ↓
Imprint Wealth LLC 23,083$78,9440.07%
Moss Adams Wealth Advisors LLC 20,000$68,4000.02%
Koshinski Asset Management, Inc. 51,001$174,4230.02%
InterOcean Capital Group, LLC 15,900$54,3780.00%
TOCQUEVILLE ASSET MANAGEMENT L.P. 12,000$41,0400.00%
Tortoise Investment Management, LLC 1,300$4,4460.00%
WELLS FARGO & COMPANY/MN 57$1950.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 73,022$249,8050.00%
STATE STREET CORP 42,960$146,9230.00%
View complete list of IMMIX BIOPHARMA INC shareholders